meta_pixel
Tapesearch Logo
Log in
Squawk on the Street

Cramer's Morning Take: Amgen, Best Buy 11/26/24

Squawk on the Street

CNBC

News, Investing, Business

4.1567 Ratings

🗓️ 26 November 2024

⏱️ 4 minutes

🧾️ Download transcript

Summary

Cramer outlines how investors should navigate the next few days. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0

Hey, it's Kramer, and this is my morning take on the market from today's CBC Investing Club morning meeting. Now this is a really weird day, okay? This is historically a very positive day. We will be overbought by the day. You know I don't like when we are overbought, but in the interim, let's just give you the little rundown here. Markets are higher, yields are back up again, but what we're reacting

0:22.2

to is retail sales, and retail sales are actually not that bad. Now, the Dow, by the way,

0:27.5

is down a lot because of Amgen. Amgen has a less than competitive drug to our Eli Lilly. I'm

0:32.7

gladly bought some of the earlier. We did not know this is going to happen. Lily also got just,

0:36.8

you know,

0:44.7

the Lillian Novo got the high sign from Medicare, Medicaid, because Biden said it is going to be covered by Medicare and Medicaid. This is a very, very big deal, because now everyone is going to be

0:48.1

covered. Once Lilly gets Medicare Medicaid, then you're going to find that you're going to be

0:53.0

able to get it, and it will be paid for most likely likely, by your insurance. So very positive. But Amgen's not so good. I'm involved with a drug that I've made. And when you have a drug that's a Me Too drug, but it has any imperfections, you can forget about it. And that is exactly where Micron is, I'm sorry, where Amgen is coming out. I want to talk about the semis for a second.

1:11.7

NVIDIA's, you can forget about it. And that is exactly where Micron is, I'm sorry, where Amgen is coming out.

1:17.3

I want to talk about the semis for a second. Invity is up, but Microns down. Now, let me give you the dichotomy here. We are, we're seeing AVI up. We're seeing all the industrial IOTs up.

1:24.0

We are seeing the companies that make anything AI down again. I want people to understand

1:31.3

that I know that Nvidia is starting to annoy people and I say give me a break. Let it come in.

1:38.6

On retail, it's Best Buy. Best Buy did not do a good quarter. They did say that the month, so far the Door Busters, November is good.

1:47.1

But the cadence of what they had from August was good, September was not so good, and October

1:51.8

bad.

1:52.8

No one's going to be buying into the idea that Corey Barry and Best Buy had a good quarter.

1:58.0

I look at it like this.

1:59.4

We have been a seller, seller, seller, seller, seller.

2:01.8

If it got to the 70s, we would start buying back stock because of that dividend and because

2:06.6

Cory Barry did say that AI is selling well the AIPC, up 5%.

2:11.8

I'm not saying it's that all that good, but be aware that I think we can start buying back

2:15.8

our stock in the 70s.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.